BRPI0511710B8 - comprimido mastigável, sugável e deglutível contendo cálcio - Google Patents

comprimido mastigável, sugável e deglutível contendo cálcio

Info

Publication number
BRPI0511710B8
BRPI0511710B8 BRPI0511710A BRPI0511710A BRPI0511710B8 BR PI0511710 B8 BRPI0511710 B8 BR PI0511710B8 BR PI0511710 A BRPI0511710 A BR PI0511710A BR PI0511710 A BRPI0511710 A BR PI0511710A BR PI0511710 B8 BRPI0511710 B8 BR PI0511710B8
Authority
BR
Brazil
Prior art keywords
tablets
suckable
chewable
calcium
swallowable
Prior art date
Application number
BRPI0511710A
Other languages
English (en)
Inventor
Wulff Sorensen Dina
Löwenstein Christensen Karin
Mohr Olsen Peder
Original Assignee
Nycomed Pharma As
Takeda As
Takeda Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34968445&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0511710(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Pharma As, Takeda As, Takeda Nycomed As filed Critical Nycomed Pharma As
Publication of BRPI0511710A publication Critical patent/BRPI0511710A/pt
Publication of BRPI0511710A8 publication Critical patent/BRPI0511710A8/pt
Publication of BRPI0511710B1 publication Critical patent/BRPI0511710B1/pt
Publication of BRPI0511710B8 publication Critical patent/BRPI0511710B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

tablete contendo cálcio, e, cassete para dispensar dose. a presente invenção diz respeito a uma composição nutracêutica e/ou farmacêutica para uso oral contendo um composto contendo cálcio. a composição está na forma de tabletes que são planejados de modo que tenham um sabor e paladar deixada na boca aceitáveis, com o qual os tabletes são mastigáveis ou sugáveis e ao mesmo tempo os tabletes satisfazem as exigências com respeito ás propriedades técnicas de modo a garantir que os tabletes possam ser dispensados por meio de uma máquina dispensadora de dose. em uma realização preferida, o tablete compreende carbonato de cálcio e sorbitol tamanho médio de partícula de 38 a 110 mícrons, em uma outra realização, os tabletes compreendem carbonato de cálcio e vitamina d como ingredientes ativos.
BRPI0511710A 2004-06-01 2005-05-24 comprimido mastigável, sugável e deglutível contendo cálcio BRPI0511710B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400860 2004-06-01
DKPA200400860 2004-06-01
PCT/DK2005/000337 WO2005117829A2 (en) 2004-06-01 2005-05-24 Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance

Publications (4)

Publication Number Publication Date
BRPI0511710A BRPI0511710A (pt) 2008-01-08
BRPI0511710A8 BRPI0511710A8 (pt) 2017-12-19
BRPI0511710B1 BRPI0511710B1 (pt) 2019-05-28
BRPI0511710B8 true BRPI0511710B8 (pt) 2021-05-25

Family

ID=34968445

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511710A BRPI0511710B8 (pt) 2004-06-01 2005-05-24 comprimido mastigável, sugável e deglutível contendo cálcio

Country Status (23)

Country Link
US (1) US8642081B2 (pt)
EP (1) EP1755578B2 (pt)
JP (1) JP4996458B2 (pt)
KR (1) KR100893847B1 (pt)
CN (1) CN1997362B (pt)
AT (1) ATE488225T1 (pt)
AU (1) AU2005249175B2 (pt)
BR (1) BRPI0511710B8 (pt)
CA (1) CA2568501C (pt)
DE (1) DE602005024800D1 (pt)
DK (1) DK1755578T4 (pt)
EA (1) EA011931B1 (pt)
GE (1) GEP20104896B (pt)
HK (1) HK1102755A1 (pt)
IL (1) IL179601A0 (pt)
MX (1) MXPA06013840A (pt)
MY (1) MY139913A (pt)
NO (1) NO343856B1 (pt)
NZ (1) NZ551692A (pt)
TW (1) TWI356713B (pt)
UA (1) UA86816C2 (pt)
WO (1) WO2005117829A2 (pt)
ZA (1) ZA200609938B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968130B2 (en) 2006-01-11 2011-06-28 Mission Pharmacal Co. Calcium-enriched food product
NZ574331A (en) * 2006-07-21 2011-01-28 Lyne Lab Liquid compositions of calcium acetate
JP2008208078A (ja) * 2007-02-27 2008-09-11 Takada Seiyaku Kk 分割錠剤
MD3856G2 (ro) * 2007-11-23 2009-10-31 Валериу ФАЛА Gumă de mestecat (variante)
MD3857G2 (ro) * 2007-12-21 2009-10-31 Валериу ФАЛА Gumă de mestecat pentru remineralizarea smalţului dentar (variante)
MD3900G2 (ro) * 2007-12-21 2009-12-31 Валериу ФАЛА Gumă de mestecat cu acţiune analgezică şi antistres (variante)
MD3878G2 (ro) * 2008-02-18 2009-11-30 Валериу ФАЛА Gumă de mestecat (variante)
JP5490691B2 (ja) * 2008-06-12 2014-05-14 株式会社三和化学研究所 炭酸カルシウム含有速崩壊性製剤
CN102238954A (zh) 2008-11-04 2011-11-09 肯塔基大学研究基金会 基于d-塔格糖的组合物以及用于预防和治疗动脉粥样硬化、代谢综合征及其症状的方法
AU2009315917B2 (en) 2008-11-17 2014-11-20 Takeda As Improved dissolution stability of calcium carbonate tablets
WO2011136093A1 (ja) * 2010-04-26 2011-11-03 味の素株式会社 減塩又は無塩飲食品用固形組成物
CN102342400A (zh) * 2011-06-28 2012-02-08 文渊 高钙木糖醇
CN103156186B (zh) * 2011-12-14 2014-11-05 中国水产舟山海洋渔业公司 一种以深海鱼鱼骨为原料的钙片及其制备方法
AU2014225449B2 (en) * 2013-03-07 2018-08-16 Amneal Pharmaceuticals Llc Stabilization of moisture-sensitive drugs
JP6554034B2 (ja) * 2013-08-09 2019-07-31 日東薬品工業株式会社 カルシウム剤
US8877240B1 (en) 2014-01-09 2014-11-04 Chemlink Laboratories, Llc Tablet binding compositions
RU2603623C2 (ru) * 2014-06-06 2016-11-27 Олег Ильич Эпштейн Ветеринарная композиция и способ улучшения жизнеспособности животных, стимуляции прироста живой массы млекопитающих и птиц, повышения эффективности иммунизации, профилактики и/или лечения инфекционных заболеваний (варианты)
EP3260114A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
CN110575440A (zh) * 2018-06-08 2019-12-17 北京新领先医药科技发展有限公司 一种碳酸钙药物组合物的制备方法
CN109730972B (zh) * 2019-03-07 2021-04-27 北京中医药大学 一种欧李钙片及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53157B1 (en) * 1981-03-09 1988-08-03 Ici Plc Coated coloured intagliated articles
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
CA1297035C (en) * 1987-12-29 1992-03-10 Warner-Lambert Canada Inc. Chewable, non-gritty calcium citrate tablet
US5204115A (en) 1990-12-12 1993-04-20 Suomen Xyrofin Oy Directly compressible xylitol and method
JP2995226B2 (ja) 1992-03-03 1999-12-27 日本ワイスレダリー株式会社 カルシウム含有チユアブル錠
US5405623A (en) * 1993-09-22 1995-04-11 Wm. Wrigley Jr. Company Chewing gum compositions and methods for manufacturing same
DE4427137B4 (de) 1993-10-07 2007-08-23 Degussa Gmbh Fällungskieselsäure
FR2724844B1 (fr) * 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
US6716454B2 (en) * 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
TW469135B (en) * 1995-10-03 2001-12-21 Chugai Pharmaceutical Co Ltd Chewable tablet
DE19617487A1 (de) 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
JP3797387B2 (ja) 1996-06-14 2006-07-19 協和醗酵工業株式会社 口腔内速崩壊錠
FR2762217B1 (fr) 1997-04-16 2000-09-29 Besins Iscovesco Lab Preparation solide vitamino-calcique, son procede d'obtention et son utilisation
ITFI970184A1 (it) 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
NZ505123A (en) * 1997-12-19 2003-07-25 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof
GB9825033D0 (en) 1998-11-13 1999-01-13 Nycomed Pharma As Process
AU5248900A (en) * 1999-06-18 2001-01-09 Takeda Chemical Industries Ltd. Quickly disintegrating solid preparations
US6256963B1 (en) * 1999-07-14 2001-07-10 Jin S. Kim Tablet cassette for automatic tablet sorting and counting machine
JP2001316249A (ja) 2000-05-11 2001-11-13 Lion Corp 錠剤型医薬組成物
US20040121006A1 (en) 2001-03-06 2004-06-24 Shoichi Narita Utilization of spray-dried powder containing sugar alcohol
KR20030081472A (ko) * 2001-03-06 2003-10-17 교와 핫꼬 고교 가부시끼가이샤 구강내 속붕괴성 제제
ES2192136B1 (es) * 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
DE20216314U1 (de) 2002-10-22 2003-12-04 Dhw Deutsche Hydrierwerke Gmbh Rodleben Sprühgetrockneter Xylitol und aus diesem hergestellte Komprimate
JP4351016B2 (ja) * 2003-10-01 2009-10-28 株式会社湯山製作所 錠剤カセット

Also Published As

Publication number Publication date
NO343856B1 (no) 2019-06-24
EP1755578B2 (en) 2018-11-28
AU2005249175B2 (en) 2008-05-08
BRPI0511710B1 (pt) 2019-05-28
TWI356713B (en) 2012-01-21
IL179601A0 (en) 2007-05-15
DE602005024800D1 (de) 2010-12-30
EA200602294A1 (ru) 2007-06-29
NZ551692A (en) 2008-12-24
MY139913A (en) 2009-11-30
CN1997362A (zh) 2007-07-11
WO2005117829A3 (en) 2006-04-27
HK1102755A1 (en) 2007-12-07
NO20066076L (no) 2007-02-14
JP2008500975A (ja) 2008-01-17
TW200600120A (en) 2006-01-01
WO2005117829A2 (en) 2005-12-15
AU2005249175A1 (en) 2005-12-15
CA2568501C (en) 2013-08-06
BRPI0511710A8 (pt) 2017-12-19
EP1755578A2 (en) 2007-02-28
WO2005117829A8 (en) 2006-07-06
US8642081B2 (en) 2014-02-04
KR20070050008A (ko) 2007-05-14
GEP20104896B (en) 2010-02-25
JP4996458B2 (ja) 2012-08-08
US20080069877A1 (en) 2008-03-20
CA2568501A1 (en) 2005-12-15
EA011931B1 (ru) 2009-06-30
CN1997362B (zh) 2010-09-08
UA86816C2 (uk) 2009-05-25
ZA200609938B (en) 2008-05-28
DK1755578T3 (da) 2011-02-28
MXPA06013840A (es) 2007-04-16
KR100893847B1 (ko) 2009-04-17
BRPI0511710A (pt) 2008-01-08
DK1755578T4 (en) 2019-03-18
ATE488225T1 (de) 2010-12-15
EP1755578B1 (en) 2010-11-17

Similar Documents

Publication Publication Date Title
BRPI0511710A8 (pt) Comprimido mastigável, sugável e deglutível contendo cálcio
ATE543489T1 (de) Orale dosierformen mit progesteron und verwendungs- und herstellungsverfahren dafür
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
UA116334C2 (uk) Тверді форми дозування бендамустину
DE602006015592D1 (de) Orodispersible pharmazeutische Zusammensetzung für die orale, oromukosale oder sublinguale Verabreichung von Agomelatin
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
MY146988A (en) Fexofenadine suspension formulation
ZA200801575B (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
DE602004011398D1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
WO2006060681A3 (en) Pharmaceutical composition containing an anti-nucleating agent
EA200701923A1 (ru) Лекарственная форма для перорального введения витамина
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
DK1511489T3 (da) Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
BR0312728A (pt) Formulação em tablete dispersìvel e processo para sua preparação
JP2006342148A5 (pt)
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
WO2007120838A3 (en) Rapidly disintegrating solid oral dosage form of liquid dispersions
UA97355C2 (ru) Фармацевтическая композиция, включающая монтелукаст
RU2014146562A (ru) Композиция, содержащая альфа-липоевую кислоту и гонокиол, для лечения нейропатий
AR076916A1 (es) Medicamento a base de calcio y de vitamina d. kit.
JP2012097034A5 (pt)
AU2003202550A1 (en) Pharmaceutical formulations with modified release
TR200704897A1 (tr) Uzatılmış salım sağlayan gliklazid formülasyonları@

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: TAKEDA NYCOMED AS (NO)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25D Requested change of name of applicant approved

Owner name: TAKEDA AS (NO)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/05/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/05/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/05/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF